# Provoked Craving Assessment

> **NCT01506908** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 323 (actual)

## Conditions studied

- Smoking Dependence
- Smoking

## Interventions

- **DRUG:** oral nicotine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01506908
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01506908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01506908, "Provoked Craving Assessment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01506908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*